SBI Funds Management

SBI Funds Management IPO

Mainboard IPO · NSE, BSE · Asset Management Company

As of , the SBI Funds Management IPO price band is ₹574 and the indicative grey-market premium (GMP) is +100 (17.42%). GMP is an unofficial, indicative figure that changes daily — not a target or recommendation.

Price band
₹574
Lot size
26 shares
Issue size
₹9812.91 Cr
GMP
+₹100 (17.42%)
Subscription
10.95x
Open date
14 July 2026
Close date
16 July 2026
Listing date
21 July 2026
Exchange
NSE, BSE
Type
Mainboard IPO

About the SBI Funds Management IPO

SBI Funds Management Ltd. is India's largest asset management company (AMC) by assets under management (AUM). The company manages the flagship SBI Mutual Fund and operates as a joint venture between State Bank of India and Amundi. Its product portfolio includes equity, debt, hybrid, index, and exchange-traded funds (ETFs), along with portfolio management services (PMS) designed to meet the needs of both retail and institutional investors. As of 2025, the company oversees approximately ₹16.32 lakh crore in AUM, accounting for nearly 15.5% of the Indian mutual fund industry's total assets. As of December 31, 2025, SBI Funds Management Ltd serves more than 16.05 million investors across individ

SBI Funds Management IPO — FAQs

The SBI Funds Management IPO price band is ₹574, with a lot size of 26 shares. Figures are indicative — confirm against the official RHP.

The grey-market premium (GMP) for SBI Funds Management is around +₹100 (17.42%). GMP is an unofficial, indicative signal from the grey market and can change daily — it is not a recommendation.

The SBI Funds Management IPO opens on 14 July 2026 and closes on 16 July 2026. Dates are subject to change per the official schedule.

All IPOs carry market risk. BuyUnlistedShares provides factual information and research, not investment advice or buy/sell recommendations. Read the RHP and assess suitability before applying.

Disclaimer: GMP and all figures are indicative and unofficial. BuyUnlistedShares provides information and research, not investment advice or buy/sell recommendations. Read the RHP before applying. Reviewed by Kanishk Dev Bangia (NISM-202300182946).

← All IPOs
Ask our AI